Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay W Mason

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Antibiotics (Basel, Switzerland)|February 7, 2017
Moxifloxacin Increases Heart Rate in HumansJay W Mason, Thomas E Moon
Clinical and Translational Science|November 11, 2018
Comparison of Electrocardiographic Biomarkers for Differentiating Drug-Induced Single vs. Multiple Cardiac Ion Channel BlockMarina Brockway, Jay W Mason, Brian P Brockway
International Journal of Cardiology|May 15, 2014
New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limitsPentti M Rautaharju, Jay W Mason, Toshio Akiyama
Clinical Pharmacology and Therapeutics|November 12, 2017
Comparison of Two Highly Automated ECG Algorithms for Detection of Drug-Induced Cardiac Ion Channel BlockMarina Brockway, Anthony A Fossa, Jay W Mason
International Journal of Cardiology|February 3, 2015
Corrigendum to "New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limits" (Internat J Cardiol 2014, IJCA 174/3 [535-540])Pentti M Rautaharju, Jay W Mason, Toshio Akiyama
Heart Rhythm|March 8, 2007
Recommendations for the standardization and interpretation of the electrocardiogram. Part II: Electrocardiography diagnostic statement list. A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm SocietyJay W Mason, E William Hancock, Leonard S Gettes, et al.
Journal of Electrocardiology|September 12, 2006
Understanding proarrhythmic potential in therapeutic drug development: alternate strategies for measuring and tracking repolarizationRobert L Lux, Leonard S Gettes, Jay W Mason
Journal of Electrocardiology|February 21, 2019
Correction of the QRS duration for heart rateJay W Mason, David G Strauss, Martino Vaglio, et al.
Cancer Management and Research|April 18, 2014
A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongationJay W Mason, Thomas E Moon, Erin O'Boyle, et al.
Clinical and Translational Science|October 29, 2018
Electrocardiographic Effects of a Supratherapeutic Dose of WCK 2349, a Benzoquinolizine FluoroquinoloneJay W Mason, Rakesh Chugh, Anasuya Patel, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Antibiotics (Basel, Switzerland)|February 7, 2017
Moxifloxacin Increases Heart Rate in HumansJay W Mason, Thomas E Moon
Clinical and Translational Science|November 11, 2018
Comparison of Electrocardiographic Biomarkers for Differentiating Drug-Induced Single vs. Multiple Cardiac Ion Channel BlockMarina Brockway, Jay W Mason, Brian P Brockway
International Journal of Cardiology|May 15, 2014
New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limitsPentti M Rautaharju, Jay W Mason, Toshio Akiyama
Clinical Pharmacology and Therapeutics|November 12, 2017
Comparison of Two Highly Automated ECG Algorithms for Detection of Drug-Induced Cardiac Ion Channel BlockMarina Brockway, Anthony A Fossa, Jay W Mason
International Journal of Cardiology|February 3, 2015
Corrigendum to "New age- and sex-specific criteria for QT prolongation based on rate correction formulas that minimize bias at the upper normal limits" (Internat J Cardiol 2014, IJCA 174/3 [535-540])Pentti M Rautaharju, Jay W Mason, Toshio Akiyama
Heart Rhythm|March 8, 2007
Recommendations for the standardization and interpretation of the electrocardiogram. Part II: Electrocardiography diagnostic statement list. A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm SocietyJay W Mason, E William Hancock, Leonard S Gettes, et al.
Journal of Electrocardiology|September 12, 2006
Understanding proarrhythmic potential in therapeutic drug development: alternate strategies for measuring and tracking repolarizationRobert L Lux, Leonard S Gettes, Jay W Mason
Journal of Electrocardiology|February 21, 2019
Correction of the QRS duration for heart rateJay W Mason, David G Strauss, Martino Vaglio, et al.
Cancer Management and Research|April 18, 2014
A randomized, placebo-controlled, four-period crossover, definitive QT study of the effects of APF530 exposure, high-dose intravenous granisetron, and moxifloxacin on QTc prolongationJay W Mason, Thomas E Moon, Erin O'Boyle, et al.
Clinical and Translational Science|October 29, 2018
Electrocardiographic Effects of a Supratherapeutic Dose of WCK 2349, a Benzoquinolizine FluoroquinoloneJay W Mason, Rakesh Chugh, Anasuya Patel, et al.
Pageof 7